Align Technology, Inc. (NASDAQ:ALGN – Get Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,840,000 shares, a growth of 19.5% from the May 31st total of 1,540,000 shares. Currently, 2.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 729,300 shares, the short-interest ratio is currently 2.5 days.
Align Technology Stock Performance
Shares of ALGN stock traded up $1.10 during trading hours on Tuesday, hitting $239.74. 460,840 shares of the company were exchanged, compared to its average volume of 769,144. The firm has a market cap of $18.05 billion, a P/E ratio of 39.50, a P/E/G ratio of 4.47 and a beta of 1.66. Align Technology has a fifty-two week low of $176.34 and a fifty-two week high of $413.20. The company has a 50 day simple moving average of $265.44 and a two-hundred day simple moving average of $283.94.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The medical equipment provider reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.08. Align Technology had a net margin of 11.80% and a return on equity of 14.15%. The business had revenue of $997.43 million during the quarter, compared to the consensus estimate of $971.97 million. As a group, sell-side analysts expect that Align Technology will post 7.86 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on ALGN
Institutional Trading of Align Technology
Hedge funds have recently bought and sold shares of the business. Mather Group LLC. acquired a new stake in Align Technology in the 1st quarter valued at $26,000. LRI Investments LLC acquired a new stake in Align Technology in the 1st quarter valued at $29,000. Crewe Advisors LLC acquired a new stake in Align Technology in the 1st quarter valued at $41,000. Lindbrook Capital LLC lifted its stake in Align Technology by 47.2% during the 1st quarter. Lindbrook Capital LLC now owns 187 shares of the medical equipment provider’s stock valued at $61,000 after acquiring an additional 60 shares in the last quarter. Finally, Orion Capital Management LLC bought a new position in Align Technology during the 3rd quarter valued at $61,000. Institutional investors and hedge funds own 88.43% of the company’s stock.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Recommended Stories
- Five stocks we like better than Align Technology
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- RXO Shares Surge Following New Acquisition Deal
- Comparing and Trading High PE Ratio Stocks
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- 5 discounted opportunities for dividend growth investors
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.